|
MEMO1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.15899999997282E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.50540000021238E-07 |
| Normal-vs-Stage2 |
9.643700E-02 |
| Normal-vs-Stage3 |
1.441570E-03 |
| Normal-vs-Stage4 |
1.284020E-02 |
| Stage1-vs-Stage2 |
4.985500E-02 |
| Stage1-vs-Stage3 |
3.901200E-01 |
| Stage1-vs-Stage4 |
1.412410E-01 |
| Stage2-vs-Stage3 |
3.287600E-01 |
| Stage2-vs-Stage4 |
6.356400E-01 |
| Stage3-vs-Stage4 |
5.245000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.15739999998021E-06 |
| Normal-vs-AfricanAmerican |
1.266240E-02 |
| Normal-vs-Asian |
2.991400E-04 |
| Caucasian-vs-AfricanAmerican |
7.593800E-01 |
| Caucasian-vs-Asian |
7.852600E-01 |
| AfricanAmerican-vs-Asian |
6.239400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.80134999999693E-05 |
| Normal-vs-Female |
1.69928000000041E-05 |
| Male-vs-Female |
2.373000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.99959999458832E-08 |
| Normal-vs-Age(41-60Yrs) |
5.572200E-04 |
| Normal-vs-Age(61-80Yrs) |
2.003600E-02 |
| Normal-vs-Age(81-100Yrs) |
4.863800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.773900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.227600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.835600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.529800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.318600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.536760E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.702600E-01 |
| Classical-VS-Follicular |
7.679000E-01 |
| Classical-VS-Other |
7.825200E-01 |
| Classical-VS-Normal |
8.44769999952533E-07 |
| Tall-VS-Follicular |
5.272400E-01 |
| Tall-VS-Other |
6.094200E-01 |
| Tall-VS-Normal |
2.790000E-02 |
| Follicular-VS-Other |
8.781400E-01 |
| Follicular-VS-Normal |
1.015090E-03 |
| Other-VS-Normal |
1.585960E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.195900E-04 |
| Normal-vs-N1 |
7.161700E-04 |
| N0-vs-N1 |
5.016000E-01 |
|
|
